Cardiopulmonary Pathology: Diseases of the Heart and Lungs

Cardiopulmonary pathology refers to disorders that affect the heart, lungs, pulmonary blood vessels, airways, chest wall, respiratory muscles, gas exchange system, and circulation. These conditions are important because the heart and lungs work together to move oxygen into the blood, remove carbon dioxide, deliver oxygen to tissues, and maintain acid-base balance.

When one part of the system fails, the other parts are often affected.

Understanding cardiopulmonary pathology requires recognizing how disease disrupts ventilation, oxygenation, perfusion, lung mechanics, cardiac output, and overall patient stability.

Overview of Cardiopulmonary Function

The cardiopulmonary system supports life by combining the work of the respiratory and cardiovascular systems. The lungs bring air into the alveoli, where oxygen moves into the blood and carbon dioxide moves out. The heart pumps blood through the pulmonary circulation for gas exchange and then through the systemic circulation to deliver oxygen to tissues.

Normal cardiopulmonary function depends on several connected processes:

• Air must move through open airways.
• The lungs must expand and recoil effectively.
• Alveoli must remain open and filled with air.
• Blood must flow through the pulmonary capillaries.
• Oxygen and carbon dioxide must diffuse across the alveolar-capillary membrane.
• The heart must pump enough blood to meet metabolic demand.
• Hemoglobin must carry oxygen to the tissues.
• The body must regulate pH through ventilation, buffering, and renal compensation.

Cardiopulmonary pathology develops when one or more of these processes are impaired. Some diseases primarily affect airflow, while others affect lung expansion, alveolar filling, pulmonary blood flow, cardiac pumping ability, or respiratory muscle function.

Many patients have more than one problem at the same time, which is why careful assessment is necessary.

Major Patterns of Cardiopulmonary Disease

Cardiopulmonary disorders can be organized by the main physiologic problem they create. This approach is often more useful than memorizing disease names alone because it helps explain why the patient is short of breath, hypoxemic, hypercapnic, fatigued, or unstable.

The major patterns include:

• Obstructive airway disease
• Restrictive lung disease
• Alveolar filling disorders
• Interstitial lung disease
• Pleural space disease
• Pulmonary vascular disease
• Cardiac dysfunction
• Acid-base disturbances
• Neuromuscular and chest wall disorders
• Trauma-related cardiopulmonary injury
• Pediatric and neonatal cardiopulmonary disorders

Note: Each pattern affects ventilation, oxygenation, perfusion, or mechanics in a different way.

Obstructive Airway Disease

Obstructive lung disease is characterized by airflow limitation, especially during exhalation. In these disorders, air has difficulty moving out of the lungs because the airways are narrowed, inflamed, plugged with mucus, weakened, or compressed. This increases airway resistance and forces the patient to generate more pressure to move air.

Common obstructive disorders include:

• Chronic obstructive pulmonary disease
• Chronic bronchitis
• Emphysema
• Asthma
• Bronchiectasis
• Cystic fibrosis
• Bronchiolitis
• Upper-airway obstruction

Note: Obstructive disease often produces wheezing, prolonged exhalation, dyspnea, chronic cough, sputum production, air trapping, and hyperinflation. Pulmonary function testing commonly shows a reduced FEV1/FVC ratio, which reflects impaired ability to force air out of the lungs.

Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a progressive disorder marked by persistent airflow obstruction that is not fully reversible. COPD often includes features of emphysema and chronic bronchitis. Cigarette smoking is the most common risk factor, but long-term exposure to harmful fumes, biomass smoke, air pollution, and genetic conditions such as alpha-1 antitrypsin deficiency can also contribute.

Patients with COPD may present with dyspnea, chronic cough, sputum production, wheezing, reduced exercise tolerance, and frequent exacerbations. As airflow obstruction worsens, the patient may develop air trapping and hyperinflation. This places the respiratory muscles at a mechanical disadvantage and increases the work of breathing.

On chest imaging, advanced COPD may show flattened diaphragms, hyperlucent lung fields, increased anteroposterior diameter, enlarged retrosternal airspaces, and a small, vertical-appearing heart. However, chest x-ray may miss early emphysema, so CT imaging is often more sensitive.

Emphysema

Emphysema is characterized by destruction and enlargement of air spaces beyond the terminal bronchioles. The loss of alveolar walls reduces the surface area available for gas exchange. It also reduces elastic recoil, which normally helps keep small airways open during exhalation.

As elastic recoil decreases, small airways collapse more easily during expiration. This causes air trapping, increased residual volume, hyperinflation, and progressive breathlessness. Lung volume testing may show increased total lung capacity, residual volume, and RV/TLC ratio. Diffusing capacity may be reduced because the alveolar-capillary surface area is destroyed.

Chronic Bronchitis

Chronic bronchitis is defined clinically by chronic productive cough caused by excessive mucus production. It is commonly associated with cigarette smoking and repeated airway irritation. The airways become inflamed, mucous glands enlarge, mucus clearance becomes impaired, and secretions accumulate.

This process narrows the airways and promotes recurrent infections. Chronic bronchitis often causes significant ventilation-perfusion mismatch because some lung regions receive blood flow but are poorly ventilated. This can lead to hypoxemia, cyanosis, hypercapnia, secondary polycythemia, pulmonary hypertension, and right-sided heart strain.

Asthma

Asthma is an obstructive airway disease marked by bronchial hyperresponsiveness, airway inflammation, and variable airflow limitation. Unlike COPD, asthma obstruction is often reversible with treatment. Symptoms may include episodic wheezing, chest tightness, cough, and shortness of breath.

During an acute asthma attack, bronchial smooth muscle constriction, mucosal edema, airway inflammation, thick secretions, and mucus plugging narrow the airways. Air trapping and alveolar hyperinflation may occur. When the lungs are already overinflated, the patient must generate large pressure changes to move a small amount of air, greatly increasing the work of breathing.

Bronchodilator testing can help identify reversible airflow limitation. When baseline spirometry is normal but asthma is still suspected, bronchoprovocation or exercise testing may help demonstrate airway hyperresponsiveness.

Bronchiectasis and Cystic Fibrosis

Bronchiectasis involves permanent abnormal dilation of bronchi or bronchioles. It often develops after repeated infections, severe pneumonia, cystic fibrosis, immune deficiency, or impaired secretion clearance. Damaged airways do not clear mucus effectively, creating a cycle of retained secretions, infection, inflammation, and further airway damage.

Patients may have chronic productive cough, purulent sputum, recurrent infections, wheezing, crackles, and sometimes hemoptysis. Chest CT is especially useful for identifying dilated airways.

Cystic fibrosis is an inherited disorder that affects exocrine glands and produces thick, sticky secretions. In the lungs, these secretions obstruct airways, impair mucociliary clearance, and promote chronic infection. Over time, airway damage, bronchiectasis, airflow obstruction, and respiratory failure may develop.

Restrictive Lung Disease

Restrictive disorders reduce lung expansion and limit the amount of air the lungs can hold. Unlike obstructive disease, where the primary problem is moving air out, restrictive disease usually involves reduced lung volumes, decreased compliance, and difficulty inflating the lungs.

Restrictive disorders may result from:

• Interstitial lung disease
• Pulmonary fibrosis
• Atelectasis
• Acute respiratory distress syndrome
• Pneumonia
• Pulmonary edema
• Pleural effusion
• Pneumothorax
• Chest wall deformities
• Obesity
• Neuromuscular weakness
• Postoperative pain or splinting

Spirometry may show a reduced forced vital capacity, but lung volume testing is needed to confirm true restriction. True restriction is present when total lung capacity is reduced below the lower limit of normal.

Patients with restrictive disorders often breathe rapidly and shallowly because taking a deep breath requires more effort. Reduced lung expansion can impair ventilation, lower oxygen levels, and increase the work of breathing.

Interstitial Lung Disease

Interstitial lung diseases affect the pulmonary interstitium, the thin region between the alveolar airspace and the pulmonary capillaries. Normally, this area is delicate and allows efficient gas exchange. In interstitial lung disease, injury, inflammation, abnormal repair, or fibrosis can thicken and damage the alveolar-capillary region.

As the interstitium becomes abnormal, oxygen transfer becomes less efficient. Gas exchange may be impaired by diffusion limitation, ventilation-perfusion mismatch, and shunting. Lung compliance decreases, meaning the lungs become stiff and difficult to expand. Patients commonly develop exertional dyspnea, reduced exercise tolerance, rapid shallow breathing, and oxygen desaturation with activity.

Common findings may include bilateral fine inspiratory crackles, especially at the lung bases. Clubbing may be present in some chronic fibrotic lung diseases. Wheezing is not typical of most interstitial disorders and may suggest associated airway disease or another obstructive process.

Imaging may show reduced lung volumes, bilateral reticular or reticulonodular opacities, architectural distortion, bronchiectasis, or honeycombing. High-resolution CT provides a more detailed view of lung pathology and is often more useful than a standard chest x-ray.

Late in the disease course, chronic hypoxemia and pulmonary vascular remodeling can contribute to pulmonary hypertension and right ventricular dysfunction. Signs may include jugular venous distention, lower-extremity edema, and reduced exercise capacity.

Alveolar Filling Disorders

Alveolar filling disorders occur when alveoli contain fluid, pus, blood, inflammatory material, or collapsed tissue instead of air. This interferes with oxygen transfer because blood continues to flow past alveoli that are not properly ventilated.

Pneumonia

Pneumonia is an infection that fills alveoli with inflammatory fluid, cells, organisms, and secretions. It may be caused by bacteria, viruses, fungi, or opportunistic pathogens. Common findings include fever, increased sputum production, cough, crackles, dyspnea, hypoxemia, and radiographic infiltrates or consolidation.

When bronchial breath sounds are heard over a lung region where vesicular breath sounds should normally be present, consolidation should be suspected. Pneumonia creates low ventilation-perfusion matching because the affected alveoli are filled with material rather than air, while perfusion may continue. This can cause hypoxemia and increased work of breathing.

Severe pneumonia can progress to respiratory failure, especially in older adults, immunocompromised patients, and those with underlying lung or heart disease. Pneumonia can also trigger sepsis or acute respiratory distress syndrome.

Pulmonary Edema

Pulmonary edema is the accumulation of watery fluid in the lung interstitium and alveoli. It is commonly associated with left ventricular failure, but it can also occur from fluid overload, low oncotic pressure, or injury to the pulmonary capillary membrane.

In cardiogenic pulmonary edema, the left ventricle fails to pump effectively. Blood backs up into the pulmonary circulation, increasing pulmonary venous and capillary pressures. Fluid then moves from the capillaries into the interstitium and alveoli. This interferes with gas exchange and reduces lung compliance.

Patients may develop dyspnea, orthopnea, crackles, hypoxemia, frothy sputum, anxiety, and severe respiratory distress. Chest imaging may show bilateral opacities, peribronchial cuffing, obscured hilar vessels, and sometimes a batwing pattern.

A key clinical distinction is whether pulmonary edema is cardiogenic or noncardiogenic. An elevated pulmonary artery wedge pressure supports cardiogenic pulmonary edema, while a normal wedge pressure suggests noncardiogenic causes such as acute respiratory distress syndrome.

Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is a severe form of noncardiogenic respiratory failure caused by diffuse injury to the alveolar-capillary membrane. It may occur after sepsis, pneumonia, aspiration, trauma, massive transfusion, pancreatitis, inhalation injury, or severe systemic inflammation.

In ARDS, endothelial and epithelial barriers are damaged. Protein-rich fluid leaks into the interstitium and alveoli. Neutrophils and inflammatory mediators enter the lung and worsen tissue injury. The alveoli become flooded, inflamed, unstable, and difficult to ventilate.

ARDS causes several major physiologic problems:

• Severe hypoxemia
• Reduced lung compliance
• Intrapulmonary shunting
• Increased work of breathing
• Diffuse bilateral infiltrates
• Refractory oxygenation problems
• High risk of ventilator-induced lung injury

Unlike cardiogenic pulmonary edema, ARDS is not primarily caused by elevated hydrostatic pressure from heart failure. Pulmonary artery wedge pressure is usually normal when measured.

Management focuses on treating the underlying trigger, supporting oxygenation, using lung-protective ventilation, applying appropriate PEEP, avoiding excessive ventilating pressures, and preventing additional injury. Severe cases may require prone positioning or other advanced supportive strategies.

Pleural Space Disorders

Pleural disorders interfere with lung expansion by occupying the pleural space or altering pleural pressure. The pleural space normally contains only a small amount of lubricating fluid. When air, blood, fluid, or infection enters this space, the lung may not expand normally.

Pleural Effusion

Pleural effusion occurs when excess fluid accumulates between the visceral and parietal pleura. It may result from heart failure, infection, malignancy, pulmonary embolism, liver disease, kidney disease, connective tissue disease, hemothorax, or chylothorax.

Heart failure commonly causes transudative pleural effusions because increased pulmonary venous pressure leads to excess interstitial fluid. When lymphatic drainage is overwhelmed, fluid may move into the pleural space. Heart-failure-related effusions are often bilateral and small, but they may be large. If unilateral, they are more commonly right-sided.

Exudative effusions result from inflammation or injury involving the lung or pleura. They contain more protein and inflammatory cells than transudates. Causes include pneumonia, tuberculosis, malignancy, viral pleurisy, connective tissue disease, drug reactions, hemothorax, and chylothorax.

On chest imaging, pleural effusion may blunt or obscure the costophrenic angle. Large effusions can compress lung tissue, reduce ventilation, and cause dyspnea. A lateral decubitus view may help determine whether the fluid moves freely or is loculated.

Pneumothorax

Pneumothorax occurs when air enters the pleural space and causes partial or complete lung collapse. It may occur spontaneously, after trauma, during mechanical ventilation, or after invasive procedures.

A tension pneumothorax is especially dangerous. Air enters the pleural space and cannot escape, causing rising intrathoracic pressure. This pushes the mediastinum away from the affected side, compresses the opposite lung, reduces venous return, and can severely decrease cardiac output.

Findings may include sudden dyspnea, chest pain, tachycardia, hypotension, diminished or absent breath sounds on one side, tracheal deviation away from the affected side, and signs of shock. Tension pneumothorax is a life-threatening emergency.

Pulmonary Vascular Disease

Pulmonary vascular disease affects blood flow through the lungs. Even when alveoli are ventilated, gas exchange cannot occur properly if perfusion is blocked or abnormal.

Pulmonary Embolism

Pulmonary embolism occurs when a clot or other material obstructs blood flow in the pulmonary arteries. It commonly originates from deep venous thrombosis. When pulmonary blood flow is blocked, alveoli may be ventilated but not perfused, increasing alveolar dead space.

Clinical findings may include sudden dyspnea, pleuritic chest pain, tachycardia, tachypnea, hypoxemia, anxiety, hemoptysis, syncope, or respiratory alkalosis from hyperventilation. Large emboli may increase pulmonary vascular resistance and strain the right ventricle.

Prevention is important in high-risk patients and may include early ambulation, pneumatic compression devices, and pharmacologic prophylaxis. Treatment commonly involves anticoagulation, with more aggressive therapy reserved for selected severe cases.

Pulmonary Hypertension

Pulmonary hypertension refers to elevated pressure in the pulmonary vascular bed. It may result from left heart disease, chronic lung disease, chronic hypoxemia, recurrent pulmonary emboli, congenital heart disease, or primary pulmonary vascular disease.

As pulmonary vascular resistance increases, the right ventricle must generate higher pressures to move blood through the lungs. Over time, this can lead to right ventricular hypertrophy, dilation, and failure.

Patients may experience exertional dyspnea, fatigue, chest discomfort, dizziness, syncope, a loud pulmonary component of the second heart sound, jugular venous distention, peripheral edema, and signs of right-sided heart failure.

Echocardiography is useful for screening, but right heart catheterization is needed for definitive diagnosis and hemodynamic classification. Management may include oxygen therapy, treatment of the underlying cause, pulmonary vasodilators in selected patients, mechanical support, or transplantation in advanced disease.

Cardiac Disorders With Respiratory Effects

Cardiac disease frequently presents with respiratory symptoms because the heart and lungs are closely connected through the pulmonary circulation. A failing heart can cause pulmonary congestion, edema, hypoxemia, and dyspnea. Lung disease can also increase pulmonary vascular resistance and strain the right side of the heart.

Congestive Heart Failure

Congestive heart failure (CHF) occurs when the heart cannot pump enough blood to meet the body’s needs. Left ventricular failure is commonly caused by coronary artery disease, myocardial infarction, cardiomyopathy, hypertension, or valvular disease.

When the left ventricle fails, pressure backs up into the left atrium and pulmonary veins. This leads to pulmonary congestion and pulmonary edema. Patients may develop dyspnea, orthopnea, paroxysmal nocturnal dyspnea, fatigue, crackles, hypoxemia, reduced exercise tolerance, and sometimes frothy sputum.

Right ventricular failure may occur secondary to left-sided heart failure, pulmonary hypertension, right ventricular infarction, chronic lung disease, or valvular disease. Findings may include jugular venous distention, peripheral edema, hepatomegaly, ascites, and systemic venous congestion.

Respiratory care priorities in acute heart failure include positioning the patient upright, monitoring oxygenation, reducing work of breathing, supporting ventilation when necessary, and recognizing decompensation. CPAP or BiPAP may improve oxygenation and reduce the workload on both the lungs and the failing heart.

Coronary Artery Disease and Acute Coronary Syndrome

Coronary artery disease occurs when narrowed or blocked coronary arteries reduce blood flow to the myocardium. When oxygen demand exceeds oxygen supply, myocardial ischemia develops. Acute coronary syndrome includes unstable angina and myocardial infarction.

Patients may report chest pain, pressure, tightness, shortness of breath, nausea, diaphoresis, fatigue, palpitations, or unexplained weakness. Some patients, especially older adults and those with diabetes, may present with dyspnea rather than classic chest pain.

ECG findings and cardiac biomarkers, especially troponin, help identify myocardial injury. Respiratory care includes assessing oxygenation, avoiding unnecessary excessive oxygen in patients who are not hypoxemic, monitoring cardiac rhythm, and watching for complications such as pulmonary edema, arrhythmias, cardiogenic shock, or cardiac arrest.

Valvular Heart Disease

Valvular heart disease can obstruct forward blood flow or allow backward flow. Both patterns increase cardiac workload and may lead to pressure overload, volume overload, pulmonary congestion, or heart failure.

Left-sided valvular disease can cause dyspnea, fatigue, murmurs, abnormal heart sounds, syncope, and signs of pulmonary edema. Severe disease may require surgical repair or valve replacement.

Patients after cardiac surgery are at risk for atelectasis, impaired cough, retained secretions, pain-limited breathing, hypoxemia, and postoperative pulmonary complications. Respiratory care may include lung expansion therapy, airway clearance, oxygen therapy, early mobilization, ventilator management, and monitoring for complications.

Cor Pulmonale

Cor pulmonale refers to right ventricular enlargement or failure caused by lung disease or pulmonary vascular disease. It is commonly associated with COPD, chronic hypoxemia, pulmonary fibrosis, sleep-disordered breathing, pulmonary hypertension, and recurrent pulmonary embolic disease.

Chronic hypoxemia can cause pulmonary vasoconstriction. When this becomes widespread, pulmonary vascular resistance increases. The right ventricle must work harder to pump blood through the lungs, eventually leading to right-sided heart strain or failure.

Clinical findings may include dyspnea, cyanosis, jugular venous distention, peripheral edema, hepatomegaly, fatigue, and sometimes polycythemia from long-standing hypoxemia. Treatment focuses on managing the underlying lung disorder, correcting hypoxemia when appropriate, and reducing right ventricular strain.

Dead Space, Shunt, and V/Q Mismatch

Gas exchange depends on matching ventilation with perfusion. When air and blood flow are not properly matched, oxygenation and carbon dioxide elimination may suffer.

Dead Space Ventilation

Dead space refers to ventilation that does not participate in gas exchange. Anatomic dead space includes the conducting airways. Alveolar dead space occurs when alveoli receive air but little or no blood flow. Physiologic dead space is the combination of both.

Pulmonary embolism, emphysema, and decreased cardiac output can increase dead space ventilation. As dead space increases, a larger portion of each breath is wasted. The patient may compensate by increasing respiratory rate or tidal volume, but this increases energy demand and may eventually lead to fatigue.

Intrapulmonary Shunt

A shunt occurs when blood passes through the lungs without being adequately oxygenated. This happens when alveoli are perfused but not ventilated. Common causes include pneumonia, atelectasis, pulmonary edema, and ARDS.

Shunting can cause severe hypoxemia that may not respond well to supplemental oxygen. Positive pressure ventilation and PEEP may be needed to recruit collapsed alveoli and improve oxygenation.

Ventilation-Perfusion Mismatch

Ventilation-perfusion mismatch occurs when ventilation and blood flow are unevenly matched. It is one of the most common causes of hypoxemia. V/Q mismatch may occur in COPD, asthma, pneumonia, atelectasis, pulmonary embolism, shock, pulmonary edema, and heart failure.

Mild to moderate V/Q mismatch often improves with supplemental oxygen. More severe mismatch may require ventilatory support, treatment of the underlying cause, and close monitoring.

Acid-Base Disturbances

Acid-base balance is a major part of cardiopulmonary pathology because ventilation directly affects carbon dioxide levels and blood pH. Normal arterial pH is approximately 7.35 to 7.45. A pH below this range indicates acidemia, while a pH above this range indicates alkalemia.

The body regulates pH through chemical buffers, the lungs, and the kidneys. Buffers respond almost immediately. The lungs respond within minutes by changing ventilation. The kidneys respond more slowly but provide powerful long-term regulation.

Respiratory Acidosis

Respiratory acidosis occurs when alveolar ventilation is inadequate and carbon dioxide rises. This may occur in COPD, severe asthma, drug overdose, respiratory muscle weakness, chest wall restriction, airway obstruction, or respiratory arrest.

As PaCO2 rises, carbonic acid increases and pH falls. If severe, respiratory acidosis can cause confusion, somnolence, arrhythmias, hemodynamic instability, and respiratory failure.

Respiratory Alkalosis

Respiratory alkalosis occurs when the patient hyperventilates and PaCO2 falls. It may occur because of hypoxemia, pain, anxiety, fever, sepsis, pulmonary embolism, pneumonia, or early respiratory distress.

A patient with pneumonia, pulmonary embolism, or heart failure may initially hyperventilate and develop respiratory alkalosis. If fatigue develops and ventilation can no longer be maintained, PaCO2 may rise and acidosis may follow.

Metabolic Acidosis and Alkalosis

Metabolic acidosis may result from shock, lactic acidosis, renal failure, diabetic ketoacidosis, or severe tissue hypoxia. The respiratory system compensates by increasing ventilation to lower PaCO2 and raise pH.

Metabolic alkalosis may occur with vomiting, diuretic therapy, or excessive bicarbonate. The respiratory system may compensate by reducing ventilation, but this compensation is limited because oxygenation must be preserved.

Severe cardiopulmonary arrest may produce combined respiratory and metabolic acidosis. Ventilation fails, carbon dioxide rises, oxygen delivery falls, and tissues produce lactic acid through anaerobic metabolism.

Neuromuscular and Chest Wall Disorders

Neurologic and neuromuscular disorders can cause respiratory failure even when the lungs are not the primary problem. These conditions impair respiratory drive, muscle strength, airway protection, cough effectiveness, or secretion clearance.

Examples include:

• Myasthenia gravis
• Guillain-Barré syndrome
• Muscular dystrophy
• Stroke
• Drug overdose
• Spinal cord injury
• Tetanus
• Severe electrolyte abnormalities
• Neurologic trauma

Patients may develop hypoventilation, atelectasis, retained secretions, aspiration, weak cough, and ventilatory failure. Assessment should focus on respiratory rate, tidal volume, vital capacity, maximal inspiratory pressure, maximal expiratory pressure, cough strength, airway protection, mental status, and blood gas trends.

Chest wall disorders can also limit ventilation. Flail chest, kyphoscoliosis, obesity, postoperative pain, trauma, and diaphragmatic dysfunction can reduce tidal volume and increase the work of breathing.

Trauma-Related Cardiopulmonary Pathology

Trauma can produce life-threatening cardiopulmonary problems. Chest trauma may cause rib fractures, pneumothorax, hemothorax, pulmonary contusion, flail chest, airway injury, or cardiac injury. These problems may impair ventilation, oxygenation, circulation, or all three.

Head trauma can impair neurologic control of breathing. Burns and smoke inhalation can injure the upper airway, lower airways, and lung tissue. Carbon monoxide poisoning interferes with oxygen transport by binding to hemoglobin, reducing the blood’s ability to carry oxygen. Drowning and hypothermia can produce severe oxygenation and ventilation failure.

In trauma, rapid assessment is essential because airway obstruction, inadequate ventilation, shock, and impaired oxygen delivery can quickly become fatal.

Pediatric and Neonatal Cardiopulmonary Pathology

Children and infants have smaller airways, less physiologic reserve, and a higher risk of rapid deterioration. A small amount of airway swelling or mucus can significantly increase resistance. Fatigue may develop quickly when work of breathing increases.

Pediatric cardiopulmonary disorders include croup, epiglottitis, bronchiolitis, asthma, cystic fibrosis, foreign body aspiration, toxic ingestion, and bronchopulmonary dysplasia.

Neonatal disorders include respiratory distress syndrome, meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, apnea of infancy, congenital heart disease, and problems requiring delivery room resuscitation.

Surfactant deficiency is especially important in neonatal respiratory distress syndrome. Without adequate surfactant, alveoli collapse more easily, compliance falls, work of breathing increases, and oxygenation worsens. Exogenous surfactant therapy may improve lung mechanics and gas exchange in selected newborns.

Assessment of Cardiopulmonary Pathology

Assessment begins with the patient’s appearance, breathing pattern, work of breathing, mental status, skin color, cough, sputum, and ability to speak. Signs such as cyanosis, accessory muscle use, labored breathing, altered mental status, or inability to speak in full sentences suggest significant compromise.

Physical assessment provides important clues:

• Wheezes suggest airway narrowing.
• Rhonchi suggest secretions in larger airways.
• Crackles may indicate pulmonary edema, pneumonia, atelectasis, or fibrosis.
• Diminished breath sounds may occur with COPD, asthma, pneumothorax, pleural effusion, obstruction, or hypoventilation.
• Tracheal deviation may suggest tension pneumothorax, atelectasis, or large pleural processes.
• Jugular venous distention and peripheral edema may suggest right-sided heart strain or fluid overload.
• An S3 gallop, murmur, or abnormal rhythm may suggest cardiac disease.

Arterial blood gases help evaluate oxygenation, ventilation, and acid-base status. A rising PaCO2 suggests worsening ventilation. A low PaO2 indicates impaired oxygenation, but interpretation must consider the level of oxygen support. A PaO2 that is only moderately low may be very concerning if the patient is receiving a high FiO2.

Chest imaging helps identify hyperinflation, infiltrates, pulmonary edema, atelectasis, pleural effusion, pneumothorax, cardiomegaly, fibrosis, and other structural abnormalities. CT imaging may detect disease patterns that plain radiographs miss.

Pulmonary function testing helps distinguish obstructive from restrictive disease and evaluates gas exchange. Spirometry, lung volumes, diffusing capacity, flow-volume loops, peak expiratory flow, respiratory muscle pressures, and exercise testing can all help define the underlying physiologic limitation.

Treatment Principles

Treatment depends on the underlying disease, but the major goals are consistent. Clinicians aim to improve oxygenation, support ventilation, reduce work of breathing, maintain airway patency, improve secretion clearance, support circulation, correct acid-base problems, and treat the primary cause.

Common treatment strategies may include:

• Supplemental oxygen for hypoxemia
• Bronchodilators for reversible airway narrowing
• Corticosteroids for airway inflammation
• Antibiotics or antivirals for infection when indicated
• Diuretics for cardiogenic pulmonary edema
• Noninvasive ventilation for selected patients with respiratory distress
• Invasive mechanical ventilation for severe ventilatory or oxygenation failure
• PEEP to improve alveolar recruitment in selected conditions
• Anticoagulation for pulmonary embolism
• Pulmonary vasodilators for selected pulmonary hypertension patients
• Airway clearance therapy for retained secretions
• Lung expansion therapy for atelectasis risk
• Rehabilitation to improve functional status
• Treatment of shock, arrhythmias, or cardiac ischemia when present

Note: Supportive ventilation does not cure the underlying disease, but it can stabilize gas exchange, reduce respiratory muscle workload, and protect vital organs while the primary condition is treated.

Cardiopulmonary Pathology Practice Questions

1. What is cardiopulmonary pathology?
Cardiopulmonary pathology refers to disorders that affect the heart, lungs, airways, pulmonary circulation, gas exchange, ventilation, oxygenation, and tissue perfusion.

2. Why are cardiopulmonary disorders often connected?
The heart and lungs work together to deliver oxygen and remove carbon dioxide, so dysfunction in one system can quickly affect the other.

3. What are the major functions disrupted by cardiopulmonary pathology?
The major functions include ventilation, oxygenation, perfusion, circulation, gas exchange, acid-base balance, and respiratory mechanics.

4. What is the main physiologic problem in obstructive lung disease?
The main problem is airflow limitation, especially difficulty moving air out of the lungs during exhalation.

5. What are common examples of obstructive lung diseases?
Common examples include COPD, asthma, chronic bronchitis, emphysema, bronchiectasis, and cystic fibrosis.

6. How does emphysema impair breathing?
Emphysema destroys alveolar walls, reduces elastic recoil, promotes airway collapse during exhalation, and causes air trapping and hyperinflation.

7. What is chronic bronchitis characterized by?
Chronic bronchitis is characterized by chronic productive cough, excessive mucus production, airway inflammation, impaired mucus clearance, and airflow obstruction.

8. How does asthma differ from COPD?
Asthma usually involves variable and reversible airflow limitation, while COPD is typically persistent and not fully reversible.

9. What changes occur during an acute asthma episode?
Bronchospasm, airway inflammation, mucosal edema, thick secretions, mucus plugging, and hyperinflation may occur.

10. Why does hyperinflation increase the work of breathing?
Hyperinflation places the lungs near the flat portion of the pressure-volume curve, requiring large pressure changes to move small volumes of air.

11. What is bronchiectasis?
Bronchiectasis is permanent abnormal dilation of the bronchi or bronchioles, often associated with chronic infection and retained secretions.

12. Why can bronchiectasis lead to recurrent infection?
Damaged and dilated airways clear secretions poorly, allowing mucus retention, bacterial growth, and repeated infection.

13. What is the key spirometry finding in obstructive lung disease?
A reduced FEV1/FVC ratio is a classic finding in obstructive lung disease.

14. What is the primary problem in restrictive lung disease?
Restrictive lung disease limits lung expansion, resulting in reduced lung volumes and decreased compliance.

15. What are common causes of restrictive lung disease?
Causes include pulmonary fibrosis, interstitial lung disease, atelectasis, ARDS, pleural effusion, pneumothorax, chest wall disorders, obesity, and neuromuscular weakness.

16. Why do patients with restrictive disease often breathe rapidly and shallowly?
Their lungs are stiff or limited in expansion, so small frequent breaths require less effort than deep breaths.

17. What confirms true restrictive lung disease on pulmonary function testing?
A reduced total lung capacity confirms true restrictive lung disease.

18. What is interstitial lung disease?
Interstitial lung disease affects the tissue between the alveoli and pulmonary capillaries, often causing inflammation, fibrosis, stiffness, and impaired gas exchange.

19. How does interstitial lung disease affect lung compliance?
It decreases lung compliance, making the lungs stiff and more difficult to expand.

20. What breath sound is commonly associated with interstitial lung disease?
Bilateral fine inspiratory crackles, especially at the lung bases, are commonly associated with interstitial lung disease.

21. Why does interstitial lung disease cause exertional dyspnea?
Oxygen diffusion becomes impaired, and the stiff lungs require more effort to expand, especially during increased activity.

22. What imaging test is especially useful for evaluating interstitial lung disease?
High-resolution CT is especially useful because it provides a detailed view of pulmonary interstitial and fibrotic changes.

23. What is pleural effusion?
Pleural effusion is the accumulation of excess fluid in the pleural space between the visceral and parietal pleura.

24. How can congestive heart failure cause pleural effusion?
Increased pulmonary venous pressure raises interstitial fluid volume, and excess fluid may move into the pleural space when lymphatic drainage is overwhelmed.

25. What is the difference between transudative and exudative pleural effusion?
Transudative effusions usually result from pressure or fluid balance problems, while exudative effusions result from inflammation, infection, malignancy, or pleural injury.

26. What are common causes of exudative pleural effusion?
Common causes include pneumonia, viral pleurisy, tuberculosis, malignancy, connective tissue disease, drug reactions, hemothorax, and chylothorax.

27. What chest x-ray finding is commonly seen with pleural effusion?
Pleural effusion commonly causes blunting or obscuring of the costophrenic angle.

28. Why can a large pleural effusion impair ventilation?
A large pleural effusion can compress lung tissue and prevent normal lung expansion.

29. What is a pneumothorax?
A pneumothorax occurs when air enters the pleural space and causes partial or complete lung collapse.

30. Why is tension pneumothorax life-threatening?
Tension pneumothorax increases pleural pressure, shifts the mediastinum, reduces venous return, compromises cardiac output, and can rapidly cause shock.

31. In which direction does the trachea shift during tension pneumothorax?
The trachea shifts away from the affected side.

32. What is pulmonary embolism?
Pulmonary embolism is obstruction of pulmonary blood flow, usually by a clot that travels from the venous system to the pulmonary arteries.

33. How does pulmonary embolism increase dead space ventilation?
Pulmonary embolism blocks perfusion to ventilated alveoli, causing air to reach lung units that are not receiving adequate blood flow.

34. What symptoms may occur with pulmonary embolism?
Sudden dyspnea, chest pain, tachycardia, tachypnea, hypoxemia, anxiety, and sometimes hemoptysis may occur.

35. Why can pulmonary embolism strain the right ventricle?
A clot can increase pulmonary vascular resistance, forcing the right ventricle to pump against higher pressure.

36. What is pulmonary hypertension?
Pulmonary hypertension is elevated pressure or resistance in the pulmonary vascular bed.

37. What test provides definitive diagnosis and hemodynamic classification of pulmonary hypertension?
Right heart catheterization provides definitive diagnosis and hemodynamic classification.

38. Why can chronic hypoxemia worsen pulmonary hypertension?
Chronic hypoxemia causes pulmonary vasoconstriction, which can increase pulmonary vascular resistance over time.

39. What is cor pulmonale?
Cor pulmonale is right ventricular enlargement or failure caused by pulmonary disease or pulmonary vascular disease.

40. What conditions are commonly associated with cor pulmonale?
COPD, chronic hypoxemia, pulmonary fibrosis, sleep-disordered breathing, and pulmonary hypertension are commonly associated with cor pulmonale.

41. What signs may suggest right-sided heart failure?
Jugular venous distention, peripheral edema, hepatomegaly, ascites, cyanosis, and systemic venous congestion may suggest right-sided heart failure.

42. What is acute respiratory distress syndrome?
Acute respiratory distress syndrome is severe noncardiogenic respiratory failure caused by diffuse injury to the alveolar-capillary membrane.

43. What happens to the alveolar-capillary membrane in ARDS?
The endothelial and epithelial barriers are damaged, allowing protein-rich fluid and inflammatory cells to enter the interstitium and alveoli.

44. Why does ARDS cause refractory hypoxemia?
ARDS causes shunting, alveolar flooding, reduced compliance, and severe gas exchange impairment, so oxygen levels may remain low despite increased oxygen support.

45. What are common triggers of ARDS?
Common triggers include sepsis, pneumonia, aspiration, trauma, massive transfusion, inhalation injury, and severe systemic inflammation.

46. How does ARDS differ from cardiogenic pulmonary edema?
ARDS is caused by alveolar-capillary injury rather than elevated hydrostatic pressure from left-sided heart failure.

47. What pulmonary artery wedge pressure finding supports ARDS rather than cardiogenic pulmonary edema?
A normal pulmonary artery wedge pressure supports ARDS rather than cardiogenic pulmonary edema.

48. What is a major ventilatory strategy used in ARDS?
Lung-protective ventilation is used to reduce ventilator-induced lung injury.

49. Why is PEEP often used in ARDS?
PEEP helps recruit collapsed alveoli, improve oxygenation, and reduce intrapulmonary shunting.

50. What severe ARDS strategy may improve oxygenation in selected patients?
Prone positioning may improve oxygenation in selected patients with severe ARDS.

51. What is congestive heart failure?
Congestive heart failure occurs when the heart cannot pump enough blood to meet the body’s metabolic demands.

52. How does left-sided heart failure affect the lungs?
Left-sided heart failure causes blood and pressure to back up into the pulmonary circulation, leading to pulmonary congestion and pulmonary edema.

53. What respiratory symptoms may occur with left ventricular failure?
Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles, hypoxemia, frothy sputum, and respiratory distress may occur.

54. Why can pulmonary edema impair oxygenation?
Fluid in the interstitium and alveoli interferes with normal gas exchange across the alveolar-capillary membrane.

55. What chest imaging pattern may be seen with pulmonary edema?
Pulmonary edema may show bilateral opacification, peribronchial cuffing, obscured hilar vessels, and sometimes a batwing pattern.

56. What hemodynamic finding supports cardiogenic pulmonary edema?
An elevated pulmonary artery wedge pressure supports cardiogenic pulmonary edema.

57. How can noninvasive ventilation help in acute pulmonary edema?
CPAP or BiPAP can improve oxygenation, reduce work of breathing, and decrease the workload imposed on the failing heart.

58. What is coronary artery disease?
Coronary artery disease is narrowing or obstruction of the coronary arteries, reducing blood flow and oxygen delivery to the myocardium.

59. What is acute coronary syndrome?
Acute coronary syndrome includes unstable angina and myocardial infarction caused by reduced blood flow to the heart muscle.

60. What symptoms may occur with acute coronary syndrome?
Chest pressure, tightness, dyspnea, diaphoresis, nausea, fatigue, palpitations, and weakness may occur.

61. Why may some patients with myocardial ischemia present mainly with shortness of breath?
Some patients, especially older adults or those with diabetes, may have atypical symptoms and present with dyspnea rather than classic chest pain.

62. What laboratory marker helps identify myocardial injury?
Troponin helps identify myocardial injury.

63. Why should excessive oxygen be avoided in nonhypoxemic acute coronary syndrome patients?
Excess oxygen is not needed when oxygenation is adequate and may be harmful in some cardiac patients.

64. How can valvular heart disease affect cardiopulmonary function?
Diseased valves can obstruct forward flow or allow backward flow, causing pressure or volume overload, pulmonary congestion, and heart failure symptoms.

65. What findings may suggest valvular heart disease?
Murmurs, abnormal heart sounds, dyspnea, fatigue, syncope, and signs of fluid overload may suggest valvular heart disease.

66. Why are postoperative pulmonary complications common after cardiac surgery?
Pain, impaired cough, retained secretions, atelectasis, hypoxemia, and reduced mobility can impair ventilation after cardiac surgery.

67. What respiratory care measures may help after cardiac surgery?
Lung expansion therapy, airway clearance, oxygen therapy, early mobilization, ventilator management, and monitoring may help reduce complications.

68. What is shock?
Shock is a life-threatening state of organ hypoperfusion with inadequate oxygen and nutrient delivery to tissues.

69. How can shock affect the respiratory system?
Shock can increase tissue hypoxia, promote lactic acidosis, increase ventilatory demand, and contribute to respiratory distress or failure.

70. What is the relationship between cardiac output and oxygen delivery?
Cardiac output helps determine how much oxygenated blood is delivered to the tissues each minute.

71. What is dead space ventilation?
Dead space ventilation occurs when part of each breath does not participate effectively in gas exchange.

72. What is the difference between anatomic and alveolar dead space?
Anatomic dead space is the conducting airway volume, while alveolar dead space occurs when alveoli are ventilated but poorly perfused.

73. What conditions can increase alveolar dead space?
Pulmonary embolism, decreased cardiac output, and emphysema can increase alveolar dead space.

74. What is ventilation-perfusion mismatch?
Ventilation-perfusion mismatch occurs when airflow and blood flow are not properly matched in the lungs.

75. What conditions can cause ventilation-perfusion mismatch?
COPD, asthma, pneumonia, atelectasis, pulmonary embolism, shock, pulmonary edema, and heart failure can cause V/Q mismatch.

76. What is intrapulmonary shunting?
Intrapulmonary shunting occurs when blood passes through the lungs without being adequately oxygenated.

77. What conditions commonly cause intrapulmonary shunting?
ARDS, severe pneumonia, atelectasis, and pulmonary edema commonly cause intrapulmonary shunting.

78. Why does shunting often respond poorly to supplemental oxygen?
Shunted blood passes through nonventilated or poorly ventilated alveoli, so increasing inspired oxygen may not fully correct hypoxemia.

79. What is a diffusion defect?
A diffusion defect occurs when gas transfer across the alveolar-capillary membrane is impaired.

80. Why does diffusion impairment usually affect oxygen more than carbon dioxide?
Oxygen is affected more because carbon dioxide diffuses more easily across the alveolar-capillary membrane.

81. What conditions can cause diffusion defects?
Interstitial lung disease, pulmonary fibrosis, pulmonary edema, inflammatory lung injury, emphysema, and pulmonary vascular disease can cause diffusion defects.

82. What is ventilatory failure?
Ventilatory failure occurs when the body cannot eliminate carbon dioxide adequately, often resulting in hypercapnia and respiratory acidosis.

83. What is oxygenation failure?
Oxygenation failure occurs when the lungs cannot transfer enough oxygen into the blood, resulting in hypoxemia.

84. What are common signs of oxygenation failure?
Dyspnea, tachypnea, tachycardia, cyanosis, hypoxemia, restlessness, and increased work of breathing may occur.

85. What are the three broad causes of cardiopulmonary failure?
The broad causes are depressed respiratory drive, excessive ventilatory workload, and failure of the ventilatory pump.

86. What is depressed respiratory drive?
Depressed respiratory drive occurs when the brain or nervous system does not provide adequate stimulation for breathing.

87. What conditions can depress respiratory drive?
Drug overdose, acute brain injury, spinal cord injury, neurologic dysfunction, sleep disorders, and compensation for metabolic alkalosis can depress respiratory drive.

88. What is excessive ventilatory workload?
Excessive ventilatory workload occurs when the effort required to breathe becomes greater than the patient can sustain.

89. What conditions can create excessive ventilatory workload?
Status asthmaticus, COPD, pulmonary embolism, shock, heart failure, pulmonary edema, ARDS, atelectasis, tension pneumothorax, and obesity can increase ventilatory workload.

90. What is ventilatory pump failure?
Ventilatory pump failure occurs when the chest wall, respiratory muscles, nerves, or lungs cannot move air effectively.

91. What conditions can cause ventilatory pump failure?
Flail chest, tension pneumothorax, neuromuscular weakness, electrolyte imbalance, respiratory muscle fatigue, and premature infant respiratory distress can cause ventilatory pump failure.

92. How can neuromuscular disease lead to respiratory failure?
Neuromuscular disease can weaken respiratory muscles, reduce tidal volume, impair cough, promote secretion retention, and cause hypoventilation.

93. What measurements help assess respiratory muscle weakness?
Vital capacity, maximal inspiratory pressure, maximal expiratory pressure, tidal volume, cough strength, and blood gas trends help assess respiratory muscle weakness.

94. Why can drug overdose cause ventilatory failure?
Drug overdose can depress the central respiratory drive, causing slow or shallow breathing and carbon dioxide retention.

95. How can atelectasis impair oxygenation?
Atelectasis collapses alveoli, reducing ventilation to perfused lung regions and creating shunt-like gas exchange impairment.

96. What imaging change may occur with atelectasis?
Atelectasis may cause volume loss and shift of the trachea or mediastinum toward the affected lung.

97. How can carbon monoxide poisoning impair oxygen delivery?
Carbon monoxide binds to hemoglobin, reducing the blood’s ability to carry oxygen to tissues.

98. Why are infants and children at higher risk for rapid respiratory deterioration?
They have smaller airways, less reserve, and can fatigue quickly when obstruction, inflammation, or work of breathing increases.

99. What is neonatal respiratory distress syndrome?
Neonatal respiratory distress syndrome is a surfactant-deficiency disorder that causes atelectasis, decreased compliance, increased work of breathing, and impaired oxygenation.

100. What is the main goal when assessing cardiopulmonary pathology?
The main goal is to identify whether the primary problem is impaired airflow, lung expansion, gas exchange, perfusion, cardiac function, oxygen transport, or ventilatory muscle strength.

Final Thoughts

Cardiopulmonary pathology is best understood by identifying the main physiologic failure. Airway disease limits airflow, restrictive disease reduces lung expansion, alveolar disease interferes with gas exchange, pleural disease prevents normal lung movement, vascular disease alters pulmonary blood flow, and cardiac disease affects circulation and pulmonary pressures.

Neuromuscular disorders may cause ventilatory failure even when the lungs are structurally normal. Effective assessment requires combining symptoms, physical findings, imaging, blood gases, pulmonary function results, and hemodynamic data.

The goal is to recognize how each disorder affects oxygenation, ventilation, perfusion, work of breathing, and patient stability.